
Shares in the company lost about half their value in Friday trading after use of the test wasn’t associated with a statistically significant reduction in late-stage cancer diagnoses.

Shares in the company lost about half their value in Friday trading after use of the test wasn’t associated with a statistically significant reduction in late-stage cancer diagnoses.
الرياض، المملكة العربية السعودية — (ARAB NEWSWIRE) — أكدت شركة الجهات الأربع السعودية، المتخصصة في…
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…
The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their booster doses…
Clinical development is still shaped by a stubborn asymmetry: only around one in ten drug candidates that enter human testing…
Mehmet Oz, a physician and TV personality, takes office as HHS lays off thousands of staffers and Republicans float potential…
AI drug developer Insilico Medicine has returned to the Hong Kong public markets with an updated IPO prospectus, targeting about $292…
Sign in to your account